Reading time: 1 minute
The healthcare industry is booming with innovation, but a handful of giants dominate R&D investments, leaving others behind. While unicorn startups are reshaping the sector, regional gaps in funding and growth create an uneven playing field. This report uncovers the key trends driving healthcare innovation and the challenges shaping its future.
The article explores the health industry's global landscape, focusing on R&D investments, unicorn startups, and scaleups. It highlights that pharmaceutical and biotech companies are among the top investors in R&D, with the US leading the sector. The rise of healthcare unicorns has been significant, but challenges like overhyped investments (e.g., Theranos) exist. In Europe, Western cities dominate healthcare scaleups, while Central-Eastern Europe lags behind due to limited funding and weaker startup ecosystems. The article emphasizes the importance of R&D intensity, venture capital, and university-driven innovation in shaping the future of healthcare entrepreneurship.
